Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2014 (2014), Article ID 435202, 9 pages
http://dx.doi.org/10.1155/2014/435202
Research Article

Drug Utilization Pattern in Patients with Different Types of Dementia in Western India

1Department of Pharmacology, Ramanbhai Patel College Of Pharmacy, Charotar University of Science and Technology, Changa, Anand, Gujarat 388421, India
2Department of Pharmacology, Pramukhswami Medical College, HM Patel Centre Medical Care & Education, Gokalnagar, Karamsad, Anand, Gujarat 388325, India
3Department of Neurology, Pramukhswami Medical College, Karamsad, Anand, Gujarat 388325, India

Received 29 May 2014; Accepted 15 August 2014; Published 27 August 2014

Academic Editor: Ricardo Nitrini

Copyright © 2014 Mansi Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Smith, “The worldwide challenge of the dementias: a role for B vitamins and homocysteine?” Food and Nutrition Bulletin, vol. 29, no. 2 supplement, pp. S143–S172, 2008. View at Google Scholar · View at Scopus
  2. R. N. Kalaria, G. E. Maestre, R. Arizaga et al., “Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors,” The Lancet Neurology, vol. 7, no. 9, pp. 812–826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Das and T. K. Banerjee, “Stroke: indian scenario,” Circulation, vol. 118, no. 25, pp. 2719–2724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Chandra, M. Ganguli, R. Pandav, J. Johnston, S. Belle, and S. T. DeKosky, “Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study,” Neurology, vol. 51, no. 4, pp. 1000–1008, 1998. View at Google Scholar · View at Scopus
  5. C. P. Ferri, M. Prince, C. Brayne et al., “Global prevalence of dementia: a Delphi consensus study,” The Lancet, vol. 366, no. 9503, pp. 2112–2117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Prasad, H. Gupta, S. Bharath et al., “Clinical practice with antidementia and antipsychotic drugs: audit from a geriatric clinic in India,” Indian Journal of Psychiatry, vol. 51, no. 4, pp. 272–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. S. Knopman, S. T. DeKosky, J. L. Cummings et al., “Practice parameter: diagnosis of dementia (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology,” Neurology, vol. 56, no. 9, pp. 1143–1153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Flaten, C. Laurent, J. E. Coelho et al., “From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?” Biochemical Society Transactions, vol. 42, no. 2, pp. 587–592, 2014. View at Publisher · View at Google Scholar
  9. R. George-Carey, D. Adeloye, K. Y. Chan et al., “An estimate of the prevalence of dementia in Africa: a systematic analysis,” Journal of Global Health, vol. 2, no. 2, Article ID 020401, 2012. View at Google Scholar
  10. C. Ballard, A. Corbett, and S. Sharp, “Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimers disease,” Expert Review of Neurotherapeutics, vol. 11, no. 3, pp. 327–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Gil-Néciga and A. L. Gobartt, “Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (TRAIN study),” Revista de Neurologia, vol. 46, no. 8, pp. 461–464, 2008. View at Google Scholar · View at Scopus
  12. E. Jeschke, T. Ostermann, H. C. Vollmar, M. Tabali, F. Schad, and H. Matthes, “Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians,” BMC Neurology, vol. 11, article 99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Ruitenberg, A. Ott, J. C. van Swieten, A. Hofman, and M. M. B. Breteler, “Incidence of dementia: does gender make a difference?” Neurobiology of Aging, vol. 22, no. 4, pp. 575–580, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Qian, T. A. Schweizer, and C. E. Fischer, “Impact of socioeconomic status on initial clinical presentation to a memory disorders clinic,” International Psychogeriatrics, vol. 26, no. 4, pp. 597–603, 2014. View at Google Scholar
  15. W. A. Kukull, E. B. Larson, L. Teri, J. Bowen, W. McCormick, and M. L. Pfanschmidt, “The mini-mental state examination score and the clinical diagnosis of dementia,” Journal of Clinical Epidemiology, vol. 47, no. 9, pp. 1061–1067, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Alladi, S. Mekala, S. K. Chadalawada, S. Jala, R. Mridula, and S. Kaul, “Subtypes of dementia: a study from a memory clinic in India,” Dementia and Geriatric Cognitive Disorders, vol. 32, no. 1, pp. 32–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Poblador-Plou, A. Calderon-Larranaga, J. Marta-Moreno et al., “Comorbidity of dementia: a cross-sectional study of primary care older patients,” BMC Psychiatry, vol. 14, article 84, 2014. View at Google Scholar
  18. T. Rungsanpanya, W. Muangpaisan, and R. Praditsuwan, “Clinical practice with antidementia drugs in a Geriatric clinic,” Journal of the Medical Association of Thailand, vol. 95, no. 8, pp. 1081–1089, 2012. View at Google Scholar · View at Scopus
  19. L. Mucha, S. Shaohung, B. Cuffel, T. McRae, T. L. Mark, and M. del Valle, “Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease,” Journal of Managed Care Pharmacy, vol. 14, no. 5, pp. 451–461, 2008. View at Google Scholar · View at Scopus
  20. S. G. Di Santo, F. Prinelli, F. Adorni, C. Caltagirone, and M. Musicco, “A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 35, no. 2, pp. 349–361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-L. Laroche, M.-C. Perault-Pochat, I. Ingrand et al., “Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study,” Pharmacoepidemiology and Drug Safety, vol. 22, no. 9, pp. 952–960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. M. Langballe, B. Engdahl, G. Selbæk, and H. Nordeng, “Concomitant use of anti-dementia drugs with psychotropic drugs in Norway—a population-based study,” Pharmacoepidemiology and Drug Safety, vol. 20, no. 12, pp. 1319–1326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. N. Tariot, J. M. Ryan, A. P. Porsteinsson, R. Loy, and L. S. Schneider, “Pharmacologic therapy for behavioral symptoms of Alzheimer's disease,” Clinics in Geriatric Medicine, vol. 17, no. 2, pp. 359–376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Martinez, R. W. Jones, and S. Rietbrock, “Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study,” BMJ Open, vol. 3, no. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Sultzer, S. M. Davis, P. N. Tariot et al., “Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial,” The American Journal of Psychiatry, vol. 165, no. 7, pp. 844–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. V. Jeste, D. Blazer, D. Casey et al., “ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia,” Neuropsychopharmacology, vol. 33, no. 5, pp. 957–970, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. H. Ford, L. Flicker, J. Thomas, P. Norman, K. Jamrozik, and O. P. Almeida, “Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial,” The Journal of Clinical Psychiatry, vol. 69, no. 8, pp. 1203–1209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. E. H. Reynolds, “The neurology of folic acid deficiency,” Handbook of Clinical Neurology, vol. 120, pp. 927–943, 2014. View at Google Scholar